Over the past 30 years, many randomized clinical trials (RCTs) and systematic reviews3,4,5,6,7,8 that evaluated the therapeutic effects of various fluid resuscitation therapies on sepsis concluded that crystalloid and albumin were the most beneficial therapeutic agents, while use of artificial colloid was associated with a higher death rate and with adverse events. Here, ALB is linked to Sepsis.